吳登強　　Deng-Chyang Wu

聯絡電話：(公) 07-3121101-7451

E-MAIL：dechwu@yahoo.com

傳真號碼：07-3135612

• 主要學歷

• 現職及專長相關之經歷
  

專長

獎勵

1. 高雄醫學大學2007年及2010年研究傑出教師獎
2. 2005年工業衛生暨環境職業醫學學術研討會優秀論文競賽獎
3. 台灣消化系醫學會最佳論文獎2009、2010、2011

Editor board
Therapeutic Advances in gastroenterology
Journal of Digestive Diseases
Kaohsiung J Med Sci
Gastroenterology Practice Research

期刊論文

1. Hsu PI, Chen WC, Tsay FW, Shihs CA, Kao SS, Wang HM, Yu HC, Lai KH, Tseng HH, Peng NJ, Chen A, Kuo CH, Wu DC* and On behalf of the Taiwan Acid-Related Disease (TARD) Study Group. 10-day quadruple therapy comprising proton pump inhibitor, bismuth, tetracycline and levofloxacin achieves a high eradication rate for H pylori infection after failure of sequential therapy. Helicobacter 2013 in press
2. Hong KJ, Wu DC, Cheng KH, Chen LT, Hung WC*. RECK inhibits stemness gene expression and tumorigenicity of gastric cancer cells by suppressing ADAM-mediated Notch1 activation. J Cell Physiol. 2013 Jul 23.
3. Hsieh MC, Wang SS, Hsieh YT, Kuo FC, Soon MS, Wu DC*. Helicobacter pylori infection associated with high HbA1c and type 2 diabetes. Eur J Clin Invest. 2013 Jun 13.
4. Wang YK, Hsu WH, Wang SS, Lu CY, Kuo FC, Su YC, Yang SF, Chen CY, Wu DC, Kuo CH*. Current pharmacological management of gastroesophageal reflux disease. Gastroenterol Res Pract. 2013;2013:983653.
5. Hsieh S, Chou HH, Hsieh CW, Wu DC, Kuo CH, Lin FH*. Hydrogen peroxide treatment of eggshell membrane to control porosity. Food Chem. 2013 Dec 1;141(3):2117-21.
6. Lin CC, Shih HY, Kuo CH, Hu HM, Chen YW, Wu DC, Su YC*. Nodular lymphoid hyperplasia in endoscopic and FDG-PET/CT ((18)F-fluoro-2-deoxyglucose positron emission tomography/computerized tomography) imaging. Kaohsiung J Med Sci. 2013 Jul;29(7):396-9.
7. Liu MK, Wu IC, Lu CY, Kuo CH, Yu FJ, Liu CJ, Hsu PI, Hsu WH, Su YC, Chen A, Wu DC, Kuo FC, Chen JJ*. Randomized trial comparing rabeprazole- versus lansoprazole-based Helicobacter pylori eradication regimens. Kaohsiung J Med Sci. 2013 Jul;29(7):379-84.
8. Cho YT, Kuo CH, Wang SS, Chen YS, Weng BC, Lee YC, Cheng CN, Shiea J*, Wu DC. Differentiation of virulence of Helicobacter pylori by matrix-assisted laser desorption/ionization mass spectrometry and multivariate analyses. Clin Chim Acta. 2013 May 26;424C:123-130.
9. Ou CH, Kuo FC, Hsu WH, Lu CY, Yu FJ, Kuo CH, Wang JY, Wu MT, Shiea J, Wu DC, Hu HM*. Comparison of the performance of guaiac-based and two immunochemical fecal occult blood tests for identifying advanced colorectal neoplasia in Taiwan. J Dig Dis. 2013 Sep;14(9):474-83.
10. Wu IC, Wu CC, Lu CY, Hsu WH, Wu MC, Lee JY, Chou SH, Lee JM, Chou YP, Wu DC, Wu MT*. Substance use (alcohol, areca nut and cigarette) is associated with poor prognosis of esophageal squamous cell carcinoma. PLoS One. 2013;8(2):e55834.
11. Chen YY, Hsu WH, Hu HM, Wu DC, Lin WY.* A case of alpha-fetoprotein-producing esophageal adenocarcinoma. Kaohsiung J Med Sci. 2013 Feb;29(2):106-10.
12. Cho YT, Chen CW, Chen MP, Hu JL, Su H, Shiea J*, Wu WJ, Wu DC. Diagnosis of albuminuria by tryptic digestion and matrix-assisted laser desorption ionization/time-of-flight mass spectrometry. Clin Chim Acta. 2013 May;420:76-81.
13. Hsu WH, Wang SS, Shih HY, Wu MC, Chen YY, Kuo FC, Yang HY, Chiu SL, Chu KS, Cheng KI, Wu DC, Lu IC*. Low effect-site concentration of propofol target-controlled infusion reduces the risk of hypotension during endoscopy in a Taiwanese population. J Dig Dis. 2013 Mar;14(3):147-52.
14. Kuo CH, Hsu PI, Kuo FC, Wang SS, Hu HM, Liu CJ, Chuah SK, Chen YH, Hsieh MC, Wu DC, Tseng HH*. Comparison of 10 day bismuth quadruple therapy with high-dose metronidazole or levofloxacin for second-line Helicobacter pylori therapy: a randomized controlled trial. J Antimicrob Chemother. 2013 Jan;68(1):222-8.
15. Cho YT, Su H, Huang TL, Chen HC, Wu WJ, Wu PC, Wu DC, Shiea J*. Matrix-assisted laser desorption ionization/time-of-flight mass spectrometry for clinical diagnosis. Clin Chim Acta. 2013 Jan 16;415:266-75.
16. Chang YT, Lin CY, Lu PL, Lai CC, Chen TC, Chen CY, Wu DC, Wang TP, Lin CM, Lin WR, Chen YH*. Stenotrophomonas maltophilia bloodstream infection: Comparison between community-onset and hospital-acquired infections. J Microbiol Immunol Infect. 2012 pii: S1684-1182(12)00175-2.
17. Huang SH, Wu IC, Wu DC, Wu CC, Yang JF, Chen YK, Chai CY, Chiu YW, Huang CT, Lee TC, Wu MT*. Occupational risks of esophageal cancer in Taiwanese men. Kaohsiung J Med Sci. 2012 Dec;28(12):654-9.
18. Yeh YS, Tsai HL, Ma CJ, Wu DC, Lu CY, Wu IC, Hou MF, Wang JY*. A retrospective study of the safety and efficacy of a first-line treatment with modified FOLFOX-4 in unresectable advanced or recurrent gastric cancer patients. Chemotherapy. 2012;58(5):411-8.
19. 吳孟杰,劉敏俐,吳登強,郭昭宏*. 抗血小板藥物的使用對消化道內視鏡相關治療影響之探討. 內科學誌 2012; 23：422-430
20. 王耀廣,胡晃鳴,許文鴻,吳登強,郭昭宏*. 從胃食道逆流疾病到巴瑞特氏食道. 內科學誌 2012; 23：254-266

21. 歐吉性,余方榮,許文鴻,王聖雯,吳登強,胡晃鳴*. 大腸直腸癌的篩檢與監測及台灣施行現況. 台灣醫界2012;55(3): 17-20

22. Hsu WH, Lu CY, Kuo FC, Kuo CH, Wu CC, Lee IL, Yu FJ, Lee JY, Chou SH, Wang JY, *Wang SW, Wu DC. Endoscopic Submucosal Dissection for Superficial Upper Gastrointestinal Neoplasms：Experience from an Endoscopic Center in South Taiwan. Gastroenterol J Taiwan 2012;29(3):268-276

23. Chuah SK, Tai WC, Hsu PI, Wu DC, Wu KL, Kuo CM, Chiu YC, Hu ML, Chou YP, Kuo YH, Liang CM, Chiu KW, Hu TH. The efficacy of second-line anti-Helicobacter pylori therapy using an extended 14-day levofloxacin/amoxicillin/proton-pump inhibitor treatment--a pilot study. Helicobacter. 2012 Oct;17(5):374-81.

24. Shih HY, Wang SS, Kuo CH, Kuo FC, Chen YY, Wu MC, Weng BC, Lee YC, Hu CT, Wu DC, Chen YH*. Comparison between Single-Dose Esomeprazole- and Pantoprazole-Based Triple Therapy on the Effectiveness for Helicobacter pylori Eradication in Taiwanese Population. Gastroenterol Res Pract. 2012;2012:674324.

25. Kuo CH, Kuo FC, Hu HM, Liu CJ, Wang SS, Chen YH, Hsieh MC, Hou MF, Wu DC*. The Optimal First-Line Therapy of Helicobacter pylori Infection in Year 2012. Gastroenterol Res Pract. 2012;2012:168361.

26. Koo JH*, Leong RW, Ching J, Yeoh KG, Wu DC, Murdani A, Cai Q, Chiu HM, Chong VH, Rerknimitr R, Goh KL, Hilmi I, Byeon JS, Niaz SK, Siddique A, Wu KC, Matsuda T, Makharia G, Sollano J, Lee SK, Sung JJ; Asia Pacific Working Group in Colorectal Cancer. Knowledge of, attitudes toward, and barriers to participation of colorectal cancer screening tests in the Asia-Pacific region: a multicenter study. Gastrointest Endosc. 2012 Jul;76(1):126-35.

27. Lin MW, Lin AS, Wu DC, Wang SS, Chang FR, Wu YC, Huang YB*. Euphol from Euphorbia tirucalli selectively inhibits human gastric cancer cell growth through the induction of ERK1/2-mediated apoptosis. Food Chem Toxicol. 2012 May 23;50(12):4333-4339.

28. Kuo CH, Kuo CC, Wu HY, Wu DC, Yang CY*. Higher parity and earlier age at first birth are associated with lower risk of death from colon cancer. Cancer Sci. 2012 Aug;103(8):1553-7.

29. Chuah SK*, Hsu PI, Wu KL, Wu DC, Tai WC, Changchien CS. 2011 update on esophageal achalasia. World J Gastroenterol. 2012 Apr 14;18(14):1573-8.

30. Chang LL, Wang SW, Wu IC, Yu FJ, Su YC, Chen YP, Wu DC*, Kuo CH, Hung CH*. Impaired dendritic cell maturation and IL-10 production following H. pylori stimulation in gastric cancer patients. Appl Microbiol Biotechnol. 2012 Oct;96(1):211-20.

31. Chuah SK, Hsu PI, Chang KC, Chiu YC, Wu KL, Chou YP, Hu ML, Tai WC, Chiu KW, Chiou SS, Wu DC, Hu TH. Randomized comparison of two non-bismuth-containing second-line rescue therapies for Helicobacter pylori. Helicobacter. 2012 Jun;17(3):216-23.

32. Huang YK, Wu MC, Wang SS, Kuo CH, Lee YC, Chang LL, Wang TH, Chen YH, Wang WM, Wu DC, Kuo FC*. Lansoprazole-based sequential and concomitant therapy for the first-line Helicobacter pylori eradication. J Dig Dis. 2012 Apr;13(4):232-8.
    Cho YT, Chen YS, Hu JL, Shiea J*, Yeh SM, Chen HC, Lee YC, Wu DC. The study of interferences for diagnosing albuminuria by matrix-assisted laser desorption ionization/time-of-flight mass spectrometry. Clin Chim Acta. 2012 May 18;413(9-10):875-82.

33. Lee CH, Lee KW, Fang FM, Wu DC, Tsai SM, Chen PH, Shieh TY, Chen CH, Wu IC, Huang HL, Chen BH, Chang CH, Chen MK, Chou SH, Tsai YS, Chiang SL, Ko YC*. The neoplastic impact of tobacco-free betel-quid on the histological type and the anatomical site of aerodigestive tract cancers. Int J Cancer. 2012 Sep 1;131(5):E733-43.

34. Tsay FW, Tseng HH, Hsu PI*, Wang KM, Lee CC, Chang SN, Wang HM, Yu HC, Chen WC, Peng NJ, Lai KH, Wu DC. Sequential therapy achieves a higher eradication rate than standard triple therapy in Taiwan. J Gastroenterol Hepatol. 2012 Mar;27(3):498-503.

35. Wu DC, Su MY, Hsu PI, Luo JC. Non-steroidal anti-inflammatory drugs-in duce d gi injuries. Gastroenterol J Taiwan 2011;28(2):249-252.

36. Shih HY, Wu DC, Huang WT, Chang YY, Yu FJ*. Glutaraldehyde-induced colitis: case reports and literature review. Kaohsiung J Med Sci. 2011 Dec;27(12):577-80.

37. Chuah SK, Tsay FW, Hsu PI*, Wu DC. A new look at anti-Helicobacter pylori therapy. World J Gastroenterol. 2011 Sep 21;17(35):3971-5.

38. Lin MY, Chen MC, Wu IC*, Wu DC, Cheng YJ, Wu CC, Chai CY, Lee JM, Wu MT*. Areca users in combination with tobacco and alcohol use are associated with younger age of diagnosed esophageal cancer in taiwanese men. PLoS One. 2011;6(10):e25347.

39. Hu TH, Chuah SK, Hsu PI, Wu DC, Tai WC, Chiu YC, Wu KL, Kuo CM, Hu ML*. Randomized Comparison of Two Nonbismuth-Containing Rescue Therapies for Helicobacter pylori. Am J Med Sci. 2011 Sep;342(3):177-81.

40. Wang SW, Lee JK, Ku CC, Chiou SS, Ho MF, Wu DC*, Yokoyama KK*. Jun Dimerization Protein 2 in Oxygen Restriction; Control of Senescence. Curr Pharm Des. 2011;17(22):2278-89 .
41. Su YC*, Chen YW, Wu DC, Wang WM, Jan CM. Duodenal ulcer disease, gastroduodenal motor function and reflux esophagitis - a cross-sectional survey in a subset of Taiwanese patients. Neurogastroenterol Motil. 2011 Sep;23(9):840-5. 
42. Huang CH, Chuang MH, Lo WL, Wu MS, Wu YH, Wu DC, Chiou SH*. Alkylhydroperoxide reductase of Helicobacter pylori as a biomarker for gastric patients with different pathological manifestations. Biochimie. 2011 Jul;93(7):1115-23. 

43. Wu DC, Hsu PI. Tseng HH, Tsai FW, Lai KH, kuo CH, Wang SW, Chen A*. Comparison of two rescue therapies for Helicobacter pylori infection after failure of standard triple therapies- a randomized, controlled study. Medicine (Baltimore). 2011 May;90(3):180-5. 

44.  

    Yeoh KG, Ho KY, Chiu HM, Zhu F, Ching JY, Wu DC, Matsuda T, Byeon JS, Lee SK, Goh KL, Sollano J, Rerknimitr R, Leong R, Tsoi K, Lin JT, Sung JJ*; for the Asia-Pacific Working Group on Colorectal Cancer. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut. 2011 Sep;60(9):1236-1241.

45. Chen CY*, Wu DC, Kang WY, Hsu JS. Erratum to: Staging of gastric cancer with 16-channel MDCT. Abdom Imaging. 2011 Feb 24. 

46.  

    Huang YC, Hasegawa H, Wang SW, Ku CC, Lin YC, Chiou SS, Hou MF, Wu DC, Tsai EM, Saito S, Yamaguchi N, Yokoyama KK*. Jun dimerization protein 2 controls senescence and differentiation via regulating histone modification. J Biomed Biotechnol. 2011;2011:569034 

47. Hsu PI, Wu DC, Wu JY, Graham DY*. Is There a Benefit to Extending the Duration of Helicobacter pylori Sequential Therapy to 14 Days? Helicobacter. 2011 Apr;16(2):146-52.

48.  

    Hsu PI, Wu DC, Wu JY, Graham DY*. Modified Sequential Helicobacter pylori Therapy: Proton Pump Inhibitor and Amoxicillin for 14 Days with Clarithromycin and Metronidazole added as a Quadruple (Hybrid) Therapy for the Final 7 Days. Helicobacter. 2011 Apr;16(2):139-45. 

49. Lu CY, Uen YH, Tsai HL, Chuang SC, Hou MF, Wu DC, Hank Juo SH, Lin SR, Wang JY*. Molecular detection of persistent postoperative circulating tumour cells in stages II and III colon cancer patients via multiple blood sampling: prognostic significance of detection for early relapse. Br J Cancer. 2011 Mar 29;104(7):1178-84.

50.  

    Lu CY, Shih YL, Sun LC, Chuang JF, Ma CJ, Chen FM, Wu DC, Hsieh JS, Wang JY*. The Inflammatory Modulation Effect of Glutamine-Enriched Total Parenteral Nutrition in Postoperative Gastrointestinal Cancer Patients. Am Surg. 2011 Jan;77(1):59-64. 

51. Chen CY, Jaw TS, Wu DC, Kuo YT, Lee CH, Huang WT, Liu GC. MDCT of giant gastric folds: differential diagnosis. AJR Am J Roentgenol. 2010 Nov;195(5):1124-30.

52.  

    Chang CC, Chen CC, Wu DC, Yang CY*. Nitrates in drinking water and the risk of death from rectal cancer: does hardness in drinking water matter? J Toxicol Environ Health A. 2010 Jan;73(19):1337-47.

53. Wu IC, Chen PH, Wang CJ, Wu DC, Tsai SM, Chao MR, Chen BH, Lee HH, Lee CH, Ko YC*. Quantification of blood betel quid alkaloids and urinary 8-hydroxydeoxyguanosine in humans and their association with betel chewing habits. J Anal Toxicol. 2010;34(6):325-31.

54.  

    Kuo CH, Wang SS, Hsu WH, Kuo FC, Weng BC, Li CJ, Hsu PI, Chen A, Hung WC, Yang YC, Wang WM, Wu DC*. Rabeprazole Can Overcome the Impact of CYP2C19 Polymorphism on Quadruple Therapy. Helicobacter. 2010 Aug;15(4):265-72. 

55. Wang JY, Yang IP, Wu DC, Huang SW, Wu JY, Juo SH*. Functional glutathione peroxidase 3 polymorphisms associated with increased risk of Taiwanese patients with gastric cancer. Clin Chim Acta. 2010 Oct 9;411(19-20):1432-6.

56.  

    Hsu WH, Wang SS, Kuo CH, Chen CY, Chang CW, Hu HM, Wang JY, Yang YC, Lin YC, Wang WM, Wu DC, Wu MT, Kuo FC*. Dual specimens increase the diagnostic accuracy and reduce the reaction duration of rapid urease test. World J Gastroenterol. 2010 Jun 21;16(23):2926-30. 

57. Chen YK, Chang WS, Wu IC, Li LH, Yang SF, Chen JY, Hsu MC, Chen SH, Wu DC, Lee JM, Huang CH, Goan YG, Chou SH, Huang CT, Wu MT*. Molecular characterization of invasive subpopulations from an esophageal squamous cell carcinoma cell line. Anticancer Res. 2010 Mar;30(3):727-36.

58.  

    Tai SY, Wu IC, Wu DC, Su HJ, Huang JL, Tsai HJ, Lu CY, Lee JM, Wu MT*. Cigarette smoking and alcohol drinking and esophageal cancer risk in Taiwanese women. World J Gastroenterol. 2010 Mar 28;16(12):1518-21. 

59. Wu IC, Wu DC, Huang CC, Lin HS, Chen YK, Tsai HJ, Lu CY, Chou SH, Chou YP, Li LH, Tai SY, Wu MT*. Plasma decorin predicts the presence of esophageal squamous cell carcinoma. Int J Cancer. 2010 Nov 1;127(9):2138-46.

60.  

    Hsu WH, Wu IC, Kuo CH, Su YC, Lu CY, Kuo FC, Jan CM, Wang WM, Wu DC, Yu FJ. Influence of proton pump inhibitor use in gastrointestinal polyps. Kaohsiung J Med Sci. 2010 Feb;26(2):76-83. 

61. Yeh JJ, Tsai S, Wu DC, Wu JY, Liu TC, Chen A*. P-selectin-dependent platelet aggregation and apoptosis may explain the decrease in platelet count during Helicobacter pylori infection. Blood. 2010 May 27;115(21):4247-53.

62.  

    Hsu PI, Chen CH, Hsiao M, Wu DC, Lin CY, Lai KH, Lu PJ. Diagnosis of gastric malignancy using gastric juice alpha1-antitrypsin. Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):405-11.

63. Ke HL, Chang LL, Yang SF, Lin HH, Li CC, Wu DC, Wu WJ*. Osteopontin overexpression predicts poor prognosis of upper urinary tract urothelial carcinoma. Urol Oncol. 2011 Nov-Dec;29(6):703-9.

64.  

    Kao YH, Chen CL, Jawan B, Chung YH, Sun CK, Kuo SM, Hu TH, Lin YC, Chan HH, Cheng KH, Wu DC, Goto S, Cheng YF, Chao D*, Tai MH*. Upregulation of hepatoma-derived growth factor is involved in murine hepatic fibrogenesis. J Hepatol. 2010 Jan;52(1):96-105.

65. Wu DC, Hsu PI, Wu JY, Opekun AR, Kuo CH, Wu IC, Wang SS, Chen A, Hung WC, Graham DY*. Sequential and Concomitant Therapy with 4 drugs are Equally Effective for Eradication of H. pylori Infection. Clin Gastroenterol Hepatol. 2010 Jan;8(1):36-41.e1.

66.  

    Yen LC, Uen YH, Wu DC, Lu CY, Yu FJ, Wu IC, Lin SR, Wang JY*. Activating KRAS Mutations and Overexpression of Epidermal Growth Factor Receptor as Independent Predictors in Metastatic Colorectal Cancer Patients Treated With Cetuximab. Ann Surg. 2010 Feb;251(2):254-60.

67. Wu MC, Wu IC, Wu JY, Wu DC, Wang WM*. Superior mesenteric artery syndrome in a diabetic patient with acute weight loss. World J Gastroenterol. 2009 Dec 21;15(47):6004-6. 

68.  

    Wang SS, Tsai SS, Hsu PC, Yang CY, Wu DC*. Concomitant Use of Clopidogrel and Proton Pump Inhibitors or Cimetidine Following Acute Myocardial Infarction Would Increase the risk of Re-Infarction. Am J Gastroenter 2009; 104(12): 3116-17

69. Chen MJ, Wu DC, Lin JM, Wu MT, Sung FC. Etiologic factors of gastric cardiac adenocarcinoma among men in Taiwan. World J Gastroenterol. 2009 Nov 21;15(43):5472-80.Wu IC, Wu DC, Yu FJ, Wang JY, Kuo CH, Yang SF, Wang CL, Wu MT. Association between Helicobacter pylori seropositivity and digestive tract cancers. World J Gastroenterol. 2009 Nov 21;15(43):5465-71.

70. Kuo CH, Hu HM, Tsai PY, Wu IC, Yang SF, Chang LL, Wang JY, Jan CM, Wang WM, Wu DC*. Short-term Celecoxib intervention is a safe and effective chemopreventive for gastric carcinogenesis based on a Mongolian gerbil model. World J Gastroenterol 2009 Oct 21;15(39):4907-14. 

71. Wang YC*, Li WY, Wu DC, Wang JJ, Wu CH, Liao JJ, Lin CK. In vitro activity of 2-methoxy-1,4-naphthoquinone and stigmasta-7,22-diene-3{beta}-ol from Impatiens balsamina L. against multiple antibiotic-resistant Helicobacter pylori. Evid Based Complement Alternat Med. 2011;2011:704721

72. Wang YC*, Wu DC, Liao JJ, Wu CH, Li WY, Weng BC. In vitro activity of Impatiens balsamina L. against multiple antibiotic-resistant Helicobacter pylori. Am J Chin Med. 2009;37(4):713-22. 

73. Tseng YS, Wu DC, Chang CY, Kuo CH, Yang YC, Jan CM, Su YC, Kuo FC, Chang LL*. Amoxicillin resistance with beta-lactamase production in Helicobacter pylori. Eur J Clin Invest. 2009 Sep;39(9):807-12

74. Wang SS, Asfaha S, Okumura T, Betz KS, Muthupalani S, Rogers AB, Tu S, Takaishi S, Jin G, Yang X, Wu DC, Fox JG, Wang TC*. Fibroblastic colony-forming unit bone marrow cells delay progression to gastric dysplasia in a helicobacter model of gastric tumorigenesis. Stem Cells. 2009 Sep;27(9):2301-11.

75. Yang YC, Wang SW, Wu IC, Chang CC, Huang YL, Lee OK, Chang JG, Chen A, Kuo FC, Wang WM, Wu DC*. A tumorigenic homeobox (HOX) gene expressing human gastric cell line derived from putative gastric stem cell. Eur J Gastroenterol Hepatol. 2009 Sep;21(9):1016-23.

76. Lee CH, Wu DC, Wu IC, Goan YG, Lee JM, Chou SH, Chan TF, Huang HL, Hung YH, Huang MC, Lai TC, Wang TN, Lan CC, Tsai S, Lin WY, Wu MT*. Genetic modulation of ADH1B and ALDH2 polymorphisms with regard to alcohol and tobacco consumption for younger aged esophageal squamous cell carcinoma diagnosis. Int J Cancer. 2009 Sep 1;125(5):1134-42.

77. Hu HM, Kuo CH, Lee CH, Wu IC, Lee KW, Lee JM, Goan YG, Chou SH, Kao EL, Wu MT, Wu DC*. Polymorphism in COX-2 modifies the inverse association between Helicobacter pylori seropositivity and esophageal squamous cell carcinoma risk in Taiwan: a case control study. BMC Gastroenterol. 2009 May 23;9:37.

78. Chen YK, Lee CH, Wu IC, Liu JS, Wu DC, Lee JM, Goan YG, Chou SH, Huang CT, Lee CY, Hung HC, Yang JF, Wu MT. Food intake and the occurrence of squamous cell carcinoma in different sections of the esophagus in Taiwanese men. Nutrition. 2009 Jul-Aug;25(7-8):753-61.

79.  

    Wu IC, Lee CH, Kuo CH, Kuo FC, Wu DC, Ko YC, Yu FJ*.Consumption of cigarette but not betel quid or alcohol increases colorectal cancer risk. J Formos Med Assoc 2009;108(2):155-163.

80. Lo YC*, Shih YT, Wu DC, Lee YC. In vitro effects of Helicobacter pylori-induced infection in gastric epithelial AGS cells on microglia-mediated toxicity in neuroblastoma SH-SY5Y cells. Inflamm Res. 2009 Jun;58(6):329-35. 

81.  

    Kuo CH, Hu HM, Kuo FC, Hsu PI, Chen A, Yu FJ, Tsai PY, Wu IC, Wang SW, Li CJ, Weng BC, Chang LL, Jan CM, Wang WM, Wu DC*. Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial. J Antimicrob Chemother. 2009 May;63(5):1017-24.

82. Tsai HL, Chang YT, Chu KS, Chen CF, Yeh YS, Ma CJ, Wu DC, Kuo CH, Chan HM, Sheen MC, Wang JY. Carcinoembryonic antigen in monitoring of response to cetuximab plus FOLFIRI or FOLFOX-4 in patients with metastatic colorectal cancer. Int J Biol Markers. 2008 Oct-Dec;23(4):244-8. 

83.  

    Chen CF, Wu DC, Chen CW, Hsieh JS, Chen CY, Wang JY. Successful management of perforated duodenal diverticulitis with intra-abdominal drainage and feeding jejunostomy: a case report and literature review. Kaohsiung J Med Sci. 2008 Aug;24(8):425-9. 

84. Chiang SL, Chen PH, Lee CH, Ko AM, Lee KW, Lin YC, Ho PS, Tu HP, Wu DC, Shieh TY, Ko YC*. Up-regulation of inflammatory signalings by areca nut extract and role of cyclooxygenase-2 -1195G>a polymorphism reveal risk of oral cancer. Cancer Res. 2008 Oct 15;68(20):8489-98. 

85.  

    Wu IC, Wu MT, Chen YK, Hsu MC, Chou SH, Lee CH, Shiea JT, Wu IL, Huang CT, Wu DC*. Apoptotic effect of Helicobacter pylori on oesophageal squamous-cell carcinoma cells in vitro. Eur J Clin Invest. 2008 Oct;38(10):760-5.

86. Wu IC, Wu MT, Chou SH, Yang SF, Goan YG, Lee JM, Chou YP, Bair MJ, Wang TE, Chen A, Chang WH, Kuo FC, Wu DC*. Osteopontin expression in squamous cell cancer of the esophagus. World J Surg. 2008 Sep;32(9):1989-95.

87.  

    Hsu PI, Jwo JJ, Yang CL, Hsu PN, Yang HB, Lai KH, Chen IS, Chuah SK, Wu DC, Chen A. Association of the myeloperoxidase polymorphism with the risk of gastric cancer. Anticancer Res. 2008 Mar-Apr;28(2B):1317-23. 

88. Chen CY, Wu DC, Kuo YT, Lee CH, Jaw TS, Kang WY, Hsu JS. MDCT for differentiation of category T1 and T2 malignant lesions from benign gastric ulcers. AJR Am J Roentgenol. 2008 Jun;190(6):1505-11.

89.  

    Hsu PI, Wu DC, Chen A, Peng NJ, Tseng HH, Tsay FW, Lo GH, Lu CY, Yu FJ, Lai KH. Quadruple rescue therapy for Helicobacter pylori infection after two treatment failures. Eur J Clin Invest. 2008 Jun;38(6):404-9.

90. Leung WK, Wu MS, Kakugawa Y, Kim JJ, Yeoh KG, Goh KL, Wu KC, Wu DC, Sollano J, Kachintorn U, Gotoda T, Lin JT, You WC, Ng EK, Sung JJ*; Asia Pacific Working Group on Gastric Cancer. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 2008 Mar;9(3):279-87. Review. (SCI)

91.  

    Kuo CH, Hu HM, Tsai PY, Yang SF, Chang LL, Wang JY, Chen A, Jan CM, Wang WM, Wu DC*. A better method for confirming Helicobacter pylori infection in Mongolian gerbils. J Gastroenterol. 2008;43(1):32-7. (SCI)

92. Ke HL, Wei YC, Yang SF, Li CC, Wu DC, Huang CH, Wu WJ*. Overexpression of hypoxia-inducible factor-1alpha predicts an unfavorable outcome in urothelial carcinoma of the upper urinary tract. Int J Urol. 2008 Mar;15(3):200-5. (SCI)

93.  

    Lee CH, Lee JM, Wu DC, Goan YG, Chou SH, Wu IC, Kao EL, Chan TF, Huang MC, Chen PS, Lee CY, Huang CT, Huang HL, Hu CY, Hung YH, Wu MT*. Carcinogenetic impact of ADH1B and ALDH2 genes on squamous cell carcinoma risk of the esophagus with regard to the consumption of alcohol, tobacco and betel quid. Int J Cancer. 2008 Mar 15;122(6):1347-56. (SCI)

94. Wu IC, Lu CY, Wu DC*. Acute hookworm infection revealed by capsule endoscopy. Endoscopy. 2007 Feb;39 Suppl 1:E306. (SCI)

95.  

    Kuo CH, Hu HM, Tsai PY, Liu CJ, Yu FJ, Chang K, Pan YS, Chen A, Jan CM, Wang WM, Wu DC*. A better method for preventing infection of percutaneous endoscopic gastrostomy. J Gastrointest Surg 2008;12(2):358-63. (SCI)

96. Lu CY, Wu DC, Wu IC, Chu KS, Sun LC, Shih YL, Chen FM, Hsieh JS, Wang JY*. Serum albumin level in the management of postoperative enteric fistula for gastrointestinal cancer patients. J Invest Surg. 2008 Jan-Feb;21(1):25-32. (SCI)

97.  

    Shiea J*, Cho YT, Lin YH, Chang CW, Lo LH, Lee YC, Ke HL, Wu WJ, Wu DC. Using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry to rapidly screen for albuminuria. Rapid Commun Mass Spectrom. 2008 Dec;22(23):3754-60.